G. Graff

781 total citations
27 papers, 660 citations indexed

About

G. Graff is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, G. Graff has authored 27 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in G. Graff's work include Inflammatory mediators and NSAID effects (6 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Synthesis and biological activity (3 papers). G. Graff is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Synthesis and biological activity (3 papers). G. Graff collaborates with scholars based in United States and Canada. G. Graff's co-authors include N D Goldberg, Linda A. Anderson, Larry W. Jaques, David B. Glass, M. K. Haddox, R. T. Holman, Walter M. Lauer, Arne Jørgen Aasen, Daniel A. Gamache and Thomas P. Krick and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Journal of Allergy and Clinical Immunology.

In The Last Decade

G. Graff

26 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Graff United States 13 288 110 106 99 77 27 660
Gustav Graff United States 20 369 1.3× 211 1.9× 142 1.3× 113 1.1× 174 2.3× 35 1.0k
Wataru Takasaki Japan 19 479 1.7× 118 1.1× 92 0.9× 63 0.6× 25 0.3× 66 1.0k
André Crastes de Paulet France 17 352 1.2× 43 0.4× 46 0.4× 105 1.1× 66 0.9× 35 814
D. R. Wing United Kingdom 16 523 1.8× 60 0.5× 65 0.6× 186 1.9× 13 0.2× 23 893
Ayako Harada Japan 17 647 2.2× 51 0.5× 38 0.4× 121 1.2× 62 0.8× 32 1.3k
Laure J. Reynolds United States 13 646 2.2× 142 1.3× 134 1.3× 135 1.4× 13 0.2× 16 971
R C Moon United States 22 875 3.0× 151 1.4× 45 0.4× 41 0.4× 57 0.7× 61 1.5k
Rubén Alvarez‐Sánchez Switzerland 15 294 1.0× 33 0.3× 38 0.4× 40 0.4× 88 1.1× 24 728
Rita Roberti Italy 22 674 2.3× 86 0.8× 229 2.2× 109 1.1× 23 0.3× 72 1.1k
Jean‐Jacques Godfroid France 15 323 1.1× 97 0.9× 69 0.7× 83 0.8× 10 0.1× 33 797

Countries citing papers authored by G. Graff

Since Specialization
Citations

This map shows the geographic impact of G. Graff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Graff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Graff more than expected).

Fields of papers citing papers by G. Graff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Graff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Graff. The network helps show where G. Graff may publish in the future.

Co-authorship network of co-authors of G. Graff

This figure shows the co-authorship network connecting the top 25 collaborators of G. Graff. A scholar is included among the top collaborators of G. Graff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Graff. G. Graff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graff, G., et al.. (2007). Characterization of COX‐1 and ‐2 inhibition by nepafenac and its metabolite, amfenac. Acta Ophthalmologica Scandinavica. 85(s240). 0–0. 1 indexed citations
2.
Graff, G., et al.. (2004). The effects of olopatadine, desloratadine, ketotifen, azelastine, and epinastine on membrane stability. Journal of Allergy and Clinical Immunology. 113(2). S328–S328. 5 indexed citations
3.
Graff, G., et al.. (2002). Bimatoprost Hydrolysis to 17-Phenyl PGF2alpha by Human and Rabbit Ocular Tissues and Agonist Activity of Bimatoprost and 17-Phenyl PGF2alpha. Investigative Ophthalmology & Visual Science. 43(13). 4080–4080. 6 indexed citations
4.
Kuszak, J.R., et al.. (2000). The Relationship Between Rabbit Lens Optical Quality and Sutural Anatomy after Vitrectomy. Experimental Eye Research. 71(3). 267–281. 21 indexed citations
5.
Yanni, John M., Steven T. Miller, Lori K. Weimer, et al.. (1996). The In Vitro and In Vivo Ocular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic Agent. Journal of Ocular Pharmacology and Therapeutics. 12(4). 389–400. 96 indexed citations
6.
Graff, G., Linda A. Anderson, & Larry W. Jaques. (1990). Preparation and purification of soybean lipoxygenase-derived unsaturated hydroperoxy and hydroxy fatty acids and determination of molar absorptivities of hydroxy fatty acids. Analytical Biochemistry. 188(1). 38–47. 90 indexed citations
7.
8.
Graff, G., Linda A. Anderson, Larry W. Jaques, & Ralph T. Scannell. (1990). Evidence for the formation of 2-hydroxyethyl esters by reaction of fatty acids with diazomethane in diethyl ether. Chemistry and Physics of Lipids. 53(1). 27–36. 4 indexed citations
9.
10.
Graff, G., Linda A. Anderson, & Leonard S. Jefferson. (1988). 269 AHR-5333, A new antiallergy compound. III. In vitro inhibition of 5-lipoxygenase and glutathione-s-transferase activity. Journal of Allergy and Clinical Immunology. 81(1). 235–235.
11.
Sapers, Gerald M., G. Graff, John G. Phillips, & K. H. Deubert. (1986). Factors Affecting the Anthocyanin Content of Cranberry. Journal of the American Society for Horticultural Science. 111(4). 612–617. 9 indexed citations
12.
Graff, G.. (1982). [49] Preparation of PGG2 and PGH2. Methods in enzymology on CD-ROM/Methods in enzymology. 86. 376–385. 18 indexed citations
13.
Bárány, Michael, Donald D. Doyle, G. Graff, William M. Westler, & John L. Markley. (1982). Changes in the natural abundance 13C NMR spectra of intact frog muscle upon storage and caffeine contracture.. Journal of Biological Chemistry. 257(6). 2741–2743. 12 indexed citations
14.
Walseth, Timothy F., G. Graff, Thomas P. Krick, & N D Goldberg. (1981). The fate of 18O in guanosine monophosphate during enzymic transformations leading to guanosine 3‘,5‘-monophosphate generation.. Journal of Biological Chemistry. 256(5). 2176–2179. 15 indexed citations
15.
Gerrard, Jon M., G. Graff, Peter C. Dedon, S. E. Kindom, & James G. White. (1981). 1-Arachidonyl-monoglyceride causes platelet aggregation—implications for an acylglycerol acylhydrolase involvement in control of prostaglandin synthesis. Progress in Lipid Research. 20. 575–578. 2 indexed citations
16.
17.
Goldberg, N D, et al.. (1978). Redox modulation of splenic cell soluble guanylate cyclase activity: activation by hydrophilic and hydrophobic oxidants represented by ascorbic and dehydroascorbic acids, fatty acid hydroperoxides, and prostaglandin endoperoxides.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 9. 101–30. 27 indexed citations
18.
Graff, G., et al.. (1978). Activation of soluble splenic cell guanylate cyclase by prostaglandin endoperoxides and fatty acid hydroperoxides. Journal of Biological Chemistry. 253(21). 7662–7676. 119 indexed citations
19.
Gerrard, J. M., et al.. (1978). Prostaglandin endoperoxides promote calcium release from a platelet membrane fraction in vitro. Prostaglandins and Medicine. 1(5). 373–385. 38 indexed citations
20.
Lauer, Walter M., Arne Jørgen Aasen, G. Graff, & R. T. Holman. (1970). Mass spectrometry of triglycerides: I. Structural effects. Lipids. 5(11). 861–868. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gustav Graff Breakdown of academic impact, for papers by Wataru Takasaki Breakdown of academic impact, for papers by André Crastes de Paulet Breakdown of academic impact, for papers by D. R. Wing Breakdown of academic impact, for papers by Ayako Harada Breakdown of academic impact, for papers by Laure J. Reynolds Breakdown of academic impact, for papers by R C Moon Breakdown of academic impact, for papers by Rubén Alvarez‐Sánchez Breakdown of academic impact, for papers by Rita Roberti Breakdown of academic impact, for papers by Jean‐Jacques Godfroid
Rankless by CCL
2026